The use of gold nanorods as a new vaccine platform against schistosomiasis-Reference-Cited by-同舟云学术

The use of gold nanorods as a new vaccine platform against schistosomiasis

Published:2018-04 Issue: Volume:275 Page:40-52
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Assis Natan R.G.,Caires Anderson J.,Figueiredo Bárbara C.,Morais Suellen B.,Mambelli Fábio S.,Marinho Fábio V.,Ladeira Luís O.,Oliveira Sergio C.^ORCID

Funder

Fapemig/PPSUS

Fapemig/Pronex

CNPq/INCT-DT

Fapemig

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference52 articles.

1. Current status of vaccines for schistosomiasis;McManus;Clin. Microbiol. Rev.,2008

2. Schistosomiasis vaccines: where do we stand?;Tebeje;Parasit. Vectors,2016

3. Chemotherapeutic approaches to trematodes (except schistosomes) and cestodes: current level of knowledge and outlook;Harder;Parasitol. Res.,2002

4. Human schistosomiasis;Gryseels;Lancet,2006

5. Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integrated approach?;Bergquist;Trends Parasitol.,2005

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of topical rSm29 in combination with intravenous meglumine antimoniate in the treatment of cutaneous leishmaniasis: A randomized controlled trial;International Journal of Infectious Diseases;2024-10

2. The efficacy of cercarial antigen loaded on nanoparticles as a potential vaccine candidate in Schistosoma mansoni-infected mice;Journal of Parasitic Diseases;2024-05-14

3. Functionalized nanomaterials targeting NLRP3 inflammasome driven immunomodulation: Friend or Foe;NANOSCALE;2023

4. Functionalized nanomaterials targeting NLRP3 inflammasome driven immunomodulation: Friend or Foe;Nanoscale;2023

5. Nano-biomaterials for therapeutic and diagnostic applications;Applications of Multifunctional Nanomaterials;2023